Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk

Annals of Surgery

Volumn 244, Issue 3, 2006, Pages 381-389

  Dalal, Kimberly Moore ^a   Kattan, Michael W ^b   Antonescu, Cristina R ^a   Brennan, Murray F ^a   Singer, Samuel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MYXOSARCOMA; NOMOGRAM; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROPERITONEUM; REVIEW; STRATIFICATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DISEASE-FREE SURVIVAL; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOSARCOMA; MALE; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROPERITONEAL NEOPLASMS; SEVERITY OF ILLNESS INDEX; SOFT TISSUE NEOPLASMS; SURVIVAL RATE;

EID: 33747637731     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000234795.98607.00     Document Type: Review

References (32)

1. Mack T. Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum, and spleen. Cancer. 1995;75:211-244.
2. Jemal A, Murray T, Ward E. , et al. Cancer Statistics, 2006. CA Cancer J Clin. 2006;56:106 -130.
3. Henricks WH, Chu YC, Goldblum Jr, et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol. 1997;21: 271-281.
4. Linehan DC, Leung J, Leung D, et al. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol. 2000;18:1637-1643.
5. Lewis J, Leung D, Woodruff J, et al. Retroperitoneal soft-tissue sarcoma. Ann Surg. 1998;228:355-365.
6. McCormick D, Mentzel T, Beham A, et al. Dedifferentiated liposarcoma: clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol. 1994;18:1213-1223.
7. Antonescu CR, Tschernyavsky SJ, Decuseara R, et al. Prognostic impact of P53 status. TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res. 2001;7:3977-3987.
8. Gebhard S, Coindre JM, Michels JJ, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2002;26:601-616.
9. Singer S, Antonescu CR, Riedel E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238:358-370.
10. Kooby DA, Antonescu CR, Brennan MF, et al. Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol. 2003;11:78-84.
11. Pisters PWT, Leung DHY, Woodruff J, et al. Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679-1689.
12. Eilber FC, Eilber FC, Eckardt J, et al. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg. 2004;240:686-695.
13. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:627-629.
14. Kattan MW, Heller G, Brennan MF. Competing risks nomogram. Statist Med. 2003;22:3515-3525.
15. Brennan MF, Kattan MW, Klimstra D, et al. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240:293-298.
16. Kattan MW, Karpeh MS, Mazumdar M, et al. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21:3647-3650.
17. Fletcher C, Unni K, Mertens F. Pathology and genetics of tumors of soft tissue and bone. In: Kleihues P, ed. World Health Organization Classification of Tumors, vol. 4. Lyon, France: International Agency for Research on Cancer Press, 2002:427.
18. Fletcher CM, Akerman P, Cin I, et al. Correlation between clinical pathological features and karyotype in lipomatous tumors. Am J Pathol. 1996;148:623-630.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Cancer Res Clin Oncol. 1958;53:457-816.
20. Harrell FE, Lee K, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
21. Kattan MW, Eastham J, Stapleton AMF, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst. 1998;90:766-771.
22. Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187-220.
23. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
24. Harrell FE Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA. 1982;247:2543-2546.
25. Harrell FE Jr. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer-Verlag, 2001:19.
26. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999;175:1499-1507.
27. Eilber FC, Brennan MF, Eilber FR, et al. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer. 2004;101:2270-2275.
28. Lewis JJ, Leung D, Espat J, et al. Effect of reresection in extremity soft tissue sarcoma. Ann Surg. 2000;231:655-663.
29. Brennan MF, Alektiar K, Maki RG. Soft tissue sarcoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins, 2001:1841-1891.
30. Eilber FC, Eilber FR. Soft tissue sarcoma. In: JL Cameron, ed. Current Surgical Therapy. St. Louis: Mosby, 2001:1213-1218.
31. Sarcoma meta-analysis collaboration. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet. 1993;350:1647-1654.
32. Grobmyer SR, Brennan MF. Predictive variables detailing the recurrence rate of soft tissue sarcomas. Curr Opin Oncol. 2003;15:319-326.